NCT05001347 A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors Status COMPLETED Phase PHASE2
NCT04996641 Endodontic-Restorative Pre-Radiation Therapy of Head and Neck Cancer Patients Status WITHDRAWN Phase NA
NCT04989725 Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer Status RECRUITING Phase PHASE2
NCT04938609 Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04936841 Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase PHASE2
NCT04933357 Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy  Status UNKNOWN Phase PHASE2/PHASE3
NCT04930432 Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT04922450 Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT04915183 Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT04910308 RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck Status ACTIVE_NOT_RECRUITING Phase NA
NCT04906070 Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan Status COMPLETED Phase NA
NCT04905134 Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase Status COMPLETED Phase NA
NCT04892875 A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers Status WITHDRAWN Phase PHASE1
NCT04883281 A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT04880603 Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site Status TERMINATED Phase PHASE2